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Abstract
Nocebo effects, i.e., adverse treatment effects which are induced by patients’ expectations,
are known to contribute to the experience of physical symptoms such as pain and itch. A
better understanding of how to minimize nocebo responses might eventually contribute to
enhanced treatment effects. However, little is known about how to reduce nocebo effects. In
the current randomized controlled study, we tested whether nocebo effects can be mini-
mized by positive expectation induction with respect to electrical and histaminic itch stimuli.
First, negative expectations about electrical itch stimuli were induced by verbal suggestion
and conditioning (part 1: induction of nocebo effect). Second, participants were randomized
to either the experimental group or one of the control groups (part 2: reversing nocebo
effect). In the experimental group, positive expectations were induced by conditioning with
verbal suggestion. In the control groups either the negative expectation induction was con-
tinued or an extinction procedure was applied. Afterwards, a histamine application test was
conducted. Positive expectation induction resulted in a significantly smaller nocebo effect
in comparison with both control groups. Mean change itch NRS scores showed that the
nocebo effect was even reversed, indicating a placebo effect. Comparable effects were also
found for histamine application. This study is the first to demonstrate that nocebo effects
can be minimized and even reversed by conditioning with verbal suggestion. The results of
the current study indicate that learning via counterconditioning and verbal suggestion repre-
sents a promising strategy for diminishing nocebo responses.
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Introduction
Nocebo effects, i.e., adverse treatment effects which are induced by patients’ expectations, play
a central role in clinical practice [1, 2]. For example, patients receiving placebos in placebo-
controlled clinical trials often report side effects similar to those experienced by patients
receiving the active treatment [2]. These effects may be merely attributed to oral and written
communication about potential adverse side effects in the informed consent procedure. Simi-
larly, nocebo-induced side effects can also occur in response to an active treatment; this
response can affect patients’ adherence and lead to withdrawal from necessary treatment [3].
Moreover, negative expectations regarding a certain treatment may reduce treatment effective-
ness itself. For example, when patients are given an analgesic drug, positive expectations
regarding its effects can double the effect, whereas negative expectations can completely abol-
ish the analgesic effect [4]. A greater understanding of nocebo effects and how to diminish
them is important for discovering ways of reducing their contribution to itch and other physi-
cal symptoms in clinical practice.
While most studies on nocebo effects derive from the field of pain, nocebo effects are also
known to play a role in a range of other symptoms and conditions, such as gastrointestinal dis-
orders, nausea, fatigue, allergic symptoms, and itch [5, 6][7]. Itch, like pain, is a common and
severe symptom of several conditions and diseases, such as dermatological and systemic dis-
eases, and can be a significant burden to patients, particularly when symptoms are chronic [8–
11]. Chronic itch is associated with, for instance, lower quality of life, impairment of sleep, feel-
ings of stigmatization, and depressive symptoms [9, 10]. Itch seems particularly susceptible to
suggestion. This is demonstrated by the phenomenon of contagious itch–e.g., watching some-
one scratch himself can induce a sensation of itch in the perceiver [12, 13]–and by several
recent studies demonstrating the role of nocebo effects on itch [14–17], by which nocebo
effects might even be larger than in pain [14]. This makes itch a useful model to investigate the
expectancy learning in nocebo effects.
With regard to expectancy learning in nocebo effects, the two expectation induction proce-
dures that have been investigated most frequently are verbal suggestion and conditioning. Ver-
bal suggestion consists of providing verbal or written information about clinical improvement
or aggravation, such as potential side effects [18]. Conditioning, on the other hand, consists of
repeatedly pairing a neutral stimulus (e.g., visual stimulus) with an active ingredient (e.g.,
increased pain stimulus), so that in time the neutral stimulus comes to elicit a similar response
as the innate response (e.g., heightened experience of pain) [18]. Numerous studies have
found evidence that verbal suggestion, conditioning and especially the combination of condi-
tioning with verbal suggestion can induce nocebo effects on physical symptoms [15, 19–21].
As far as we know, only one study investigated whether nocebo-like effects can be reduced,
using verbal suggestion procedures [22]. Reduction of nocebo effects, particularly induced via
conditioning, has so far not been explored.
Changing of conditioned effects has been studied in fear and evaluative conditioning para-
digms in particular [23–26]. Two main procedures that are used to change conditioned effects
are extinction and counterconditioning. During extinction, a conditioned stimulus (CS) that
was previously paired with e.g., a negative unconditioned stimulus (US) is now presented with-
out the US. During counterconditioning, the CS-US pairing is still presented but the valence
of the US is now opposite to the valence of the US with which it was previously paired (e.g.,
positive vs. negative) [23, 27–30]. Although extinction has been studied extensively, the results
are mixed. Counterconditioning, on the other hand, has been investigated less frequently, but
results show quite consistently that it can effectively change conditioned effects [25, 26, 31].
Counterconditioning has yet not been investigated with regard to nocebo (or placebo) effects,
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but could, in combination with verbal suggestion, prove an effective procedure to reduce
nocebo effects.
In the present study we aimed to investigate whether conditioned nocebo responses to
itch could be reduced by a positive expectation induction. Healthy participants were first
exposed to a negative expectation induction (nocebo effect induction) by a procedure that
combined conditioning and verbal suggestion regarding electrical itch stimuli. Then they
were exposed to a positive expectation induction by a procedure that combined countercon-
ditioning and verbal suggestion (placebo effect induction). In line with studies on counter-
conditioning e.g., [25, 32], control groups consisted of continued negative expectation
inductions or an extinction procedure. It was hypothesized that the positive expectation
induction would result in decreased itch in comparison with the two control groups. In
addition, we exploratively tested the extent to which previously reduced nocebo effects
would generalize to a different itch stimulus to assess external validity. Furthermore, it
was explored whether psychological characteristics related to negative or positive outcome
expectancies (e.g., worrying or optimism, respectively) were associated with (reversion of)
nocebo responses [15, 33].
Methods
Ethics statement
The study was approved by the medical ethics committee of the Leiden University Medical
Center in Leiden, the Netherlands (Commissie Medische Ethiek) and follows the rules stated
in the Declaration of Helsinki. The study was registered retrospectively at the ISRCTN registry
(registration code: ISRCTN 76895197), since this is a randomized experimental lab study in
healthy individuals. The authors confirm that all ongoing and related trials for this interven-
tion are registered. All participants gave written informed consent and were reimbursed for
participation.
Participants
In total 129 participants were included in this study. Exclusion criteria were severe physical
morbidity (e.g., skin disease, diabetes mellitus, multiple sclerosis), psychiatric disorders (e.g.,
depression), chronic itch or pain complaints, diagnosis of histamine hypersensitivity, regular
use of medication in the last 3 months, use of a pacemaker, and color blindness. All partici-
pants were of Dutch nationality, and were aged 18 years or older (mean age 20.25 ± 2.46 years;
78.7% were women.
Design
This study used a balanced (1:1:1) randomized, multi-arm parallel-group, single blind design.
The study comprised three parts: in the first part, all participants received a negative expecta-
tion induction regarding electrical itch stimuli (induction nocebo effect; part 1); in the second
part, participants were equally randomized over three experimental groups in which they
either received a positive expectation induction (induction placebo effect; group 1), a contin-
ued negative expectation induction (induction nocebo effect; group 2), or an extinction proce-
dure (extinction; group 3). In the third part, generalization of reduced nocebo effects to
another itch stimulus, histamine iontophoresis, was tested. Fig 1. displays the experimental
design.
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Fig 1. Experimental design. The study started with negative expectation induction: participants were told that the purple light (conditioned
cue) indicated an increase in the itch stimulus, and that the yellow light (neutral cue) indicated no change in the itch stimulus. In accordance
with the verbal suggestion, the purple and yellow lights were repeatedly paired with high and medium electrical itch stimulus intensities,
respectively. Subsequently, participants were randomized over the three groups in which 1) positive expectations were induced; 2)
continued negative expectations were induced; or 3) an extinction procedure was applied. In the learning phases verbal suggestion and
conditioning procedures depended on the experimental group. In the testing phase the verbal suggestion corresponded to the verbal
suggestion provided in the learning phase, while all participants received electrical itch stimuli of medium intensity. Next, generalization of
reduced nocebo effects to histamine application was tested. The verbal suggestion corresponded to the verbal suggestion provided in part 2
and the purple light (conditioned cue) was displayed during the histamine application. The intensity of the histamine application was identical
for all groups. Note that for half of the participants the conditioned cue was a purple light and the neutral cue a yellow light (like in this
example); for the other half of the participants the conditioned cue was yellow and the neutral purple.
https://doi.org/10.1371/journal.pone.0182959.g001
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Materials
Itch induction. Electrical stimulation. Itch was induced by means of electrical stimula-
tion using a constant current stimulator (Isolated Bipolar Constant Current Stimulator DS5,
Digitimer, United Kingdom), and delivered to the inner side of the non-dominant wrist
through two surface electrodes (for the detailed procedure see [15]). A third (sham) electrode
was placed approximately 1 cm to the left from of the two active electrodes and attached to the
back of the stimulator. Stimuli were applied at 50-Hz frequency with a pulse duration of 100 μs
and at a continuously increasing current intensity (0.05 mA/s), up to a maximum current
intensity of 5 mA. After each stimulus, participants verbally reported the level of itch, which
they could express up to one decimal point, using a Numerical Rating Scale (NRS) ranging
from 0.0 (no itch at all) to 10.0 (worst itch ever experienced). The NRS was attached below a
computer screen in front of the participant.
Histamine iontophoresis. Histamine was applied by iontophoresis (Chattanooga Group,
Hixson, TN, USA). A 0.3% diphosphate histamine solution was placed in an electrode (Chatta-
nooga Ionto Ultra Electrode medium), which was placed on the dominant forearm (the forearm
contralateral to the electrical itch stimulation), 2 cm distal to the lateral epicondyle of the hu-
merus. The reference electrode was applied to the skin on the lateral side of the triceps brachial
muscle. The histamine solution was delivered with a dose controller (Chattanooga ionto, Chatta-
nooga Group, Hixson, TN, USA) for 2.5 minutes at a current level of 0.4 mA. The third (sham)
electrode that was also applied during electrical stimulation, was placed approximately 1 cm to
the left from of the two histamine electrodes and attached to the back of the electrical stimulator.
Participants rated itch intensity on an NRS every 30 seconds during histamine application.
Questionnaires
Screening questionnaires on demographic variables, diseases, and physical complaints were
used to check participants for inclusion and exclusion criteria. In addition, several individual
self-report questionnaires were used to assess the following psychological characteristics: Opti-
mism (The Revised Life Orientation Test; [34]) total scale α = 0.66; Hope (The Dispositional
Hope Scale; [35]) α = 0.81; Worrying (The Penn State Worry Questionnaire; [36]) α = 0.91;
Neuroticisms and Extraversion (The Eysenck Personality Questionnaire; [37] neuroticism scale
α = 0.79, α extraversion scale = 0.85; Impulsivity (The Baratt Impulsiveness Scale; [38] α =
0.84; Self-efficacy (The General Self-Efficacy scale; [39]) α = 0.82; Negative affect (The Hospital
Anxiety and Depression Scale; [40]) total scale α = 0.79; Future expectations (The Future
Expectations questionnaire; [41]) positive scale α = 0.86, negative scale α 0.76; Positive and neg-
ative state affect (Positive and Negative Affect Schedule; [42]) positive affect scale α = 0.73. The
negative affect scale data were not analyzed due to strong floor effects (53% of participants
reported minimum score); State anxiety (short version of the State-Trait Anxiety Inventory,
State version; [43]) α = 0.69; levels of itch, pain and fatigue (Numerical rating scale (NRS); [44],
participants reported the experienced intensity of the sensations on a NRS ranging from 0.0
(no itch/ pain/ fatigue at all) to 10.0 (worst itch /pain/ fatigue ever experienced). Furthermore,
exit questions regarding the intensity of the stimuli and purpose of the study were used. All
questionnaires were administered in Dutch. With the exception of the exit questionnaires,
which were filled out on paper, all questionnaires were completed using Qualtrics (Qualtrics,
Provo, Utah, United States).
Procedure
The study was conducted at the Leiden University, Leiden, the Netherlands, from September
2014 to July 2015. Participants were recruited via an online recruitment system of Leiden
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University (Sona Systems, Tallinn, Estonia) and through flyers posted in the campus of the Lei-
den University, Leiden, the Netherlands. Participants were informed that the purpose of the
study was to determine sensitivity to itch stimuli; the full purpose of the study was not revealed
until after the experiment was finished. An online self-report questionnaire was used to screen
participants for inclusion and exclusion criteria, and eligible participants were scheduled for
an appointment. Next, participants filled out an additional online self-report questionnaires
assessing personality traits.
All participants were asked to refrain from taking any medication, alcohol, and drugs for 24
hours before the test day, and from smoking cigarettes or drinking coffee, tea, cola, or energy
drinks for two hours before testing. The experiment took place at a standard time (start at 11
am, duration ca. 5 hours and 30 minutes). First, all participants gave their written informed
consent. Subsequently, baseline itch, pain, and fatigue were assessed using NRSs, and question-
naires on mood factors were administered. Before electrical stimulation, all participants held
their hands in a warm water bath at about 32˚C for 3 minutes in order to attain a comparable
baseline wrist skin temperature among participants [15]. Next, the intensities of low, medium,
and high stimuli were calibrated for each participant individually by gradually increasing the
intensity of the electrical current with a ramping procedure (for the detailed procedure see
[15]). The individually determined medium and high itch stimuli were used in part 1, and the
low, medium and high itch stimuli were used in part 2 of this study.
In part 1, negative expectations regarding itch stimuli were induced in all participants by
conditioning with verbal suggestion (part 1; induction of nocebo effect). Participants were told
that they would receive a series of electrical itch stimuli with and without activation of a third
electrode that influenced the itch intensity. This third electrode was actually never activated,
since it was a sham electrode, serving as the ‘placebo’ in this experiment. Itch stimuli were
accompanied by visual cues on a computer screen, i.e., purple and yellow colored circles. To
control for effects of the colors, for half of the participants the conditioned cue was a purple
circle and the neutral cue a yellow circle, and vice versa for the other half of the participants
(an independent data manager generated an unpredictable random sequence via SPSS 23.0 for
Windows; IBM SPSS Statistics, Chicago, Illinois, USA). Allocation to color was concealed by
using sequentially numbered, opaque, envelopes that the experimenter opened just before the
start of the learning phase in part 1 (1:1 allocation). The color was written on a folded sealed
note. Participants were told: “A purple/ yellow light will signal the activation of the third elec-
trode that induces an increase in the intensity of the itch stimulus, and the yellow/ purple light
will indicate that the third electrode is turned off and will not change the intensity of the itch
stimulus”. Conditioning was achieved by surreptitiously increasing the intensity of the itch sti-
muli on the conditioned trials relative to the neutral trials.
In part 2, a computer generated randomization list (generated by the independent data
manager using SPSS 23.0 for Windows; stratified by sex; with a 1:1:1 allocation) was used to
assign participants randomly to one of the three groups (which differed only in the verbal sug-
gestion and conditioning procedure). Just before the learning phase of part 2 started, the
experimenter opened a second sealed note in the envelope in which the experimental condi-
tion was revealed. Participants were unaware of randomization or differences between groups
during the experiment.
In the positive expectation induction group (induction of placebo effect; group 1), expecta-
tions of low and medium levels of itch were now raised in the participants: “A purple/ yellow
light will signal the activation of the third electrode, which will now induce a decrease in the
intensity of the itch stimulus, and the yellow/ purple light will indicate that the third electrode
is turned off and will not change the intensity of the itch stimulus”. In accordance with the ver-
bal suggestion, conditioning was now achieved by surreptitiously decreasing the intensity of
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the itch stimuli on the conditioned trials relative to the neutral trials. In the negative expecta-
tion induction group (induction of nocebo effect; group 2), exactly the same procedure was
applied as in the first part of the experiment. In the extinction group (extinction; group 3), no
verbal suggestion was provided, i.e., participants were not given any information about the col-
ored cues or stimulus intensity and all stimuli were applied at medium intensity.
In line with previous studies of conditioning in relation to nocebo and placebo effects on
pain e.g.,[19, 45] and with a previous study of our own [15], the experimental session com-
prised two phases: a learning phase and a testing phase. The learning phase consisted of 16 tri-
als in total: 10 conditioned trials with supposed activation of the third (sham) electrode, and 6
neutral trials without activation of the third electrode. These trials were presented in a quasi-
random order for each participant i.e., there were no more than two conditioned trials in a
row. The testing phase consisted of 8 trials in total: 4 conditioned trials and 4 neutral trials,
again in quasi-random order, all followed by itch stimuli of medium intensity. Conditioning
took place only in the learning phase, but verbal suggestions were also repeated in the testing
phase; the suggestions were the same as in the learning phase.
Each trial consisted of a single itch stimulus, which was accompanied by a visual colored
cue (purple or yellow) on a computer screen. To announce the start of a trial, every itch stimu-
lus was preceded by a flashing colored cue of one second on the computer screen. Between
each electrical itch stimulus applied in the learning and testing phases, there was a 2-minute
interval, in which filler tasks (“find the differences” tasks, “word search puzzles”, and “Sudoku
puzzles”) were given to diminish possible influence on subsequent stimuli of itch evoked by
previously applied stimuli. The interval could be extended to a maximum of 4 minutes if the
level of itch after 2 minutes was2.0 on an NRS.
In part 3, histamine iontophoresis followed, using the same verbal suggestion as in part 2
and displaying the same conditioned cue on the computer screen during administration of the
histamine itch stimulus using distinct electrodes. Participants were told that histamine would
be applied to the skin through a light electrical current and that the skin could get red and
thicker, similar to a mosquito bite. Before histamine was applied, participants indicated base-
line levels of itch, pain, and fatigue. Then, participants were told: “During the itch stimulus,
again a colored cue will be displayed at the computer screen. This will either be or a purple
light, or a yellow light”. In the positive expectation induction group (induction of placebo
effect; group 1), participants were told: “The purple/ yellow light will indicate a significant
decrease in itch, and the yellow/ purple light will indicate that the itch remains unchanged”. In
the negative expectation induction group (induction of nocebo effect; group 2), participants
were told: “The purple/ yellow light will indicate a significant increase in itch, and the yellow/
purple light will indicate that the itch remains unchanged”. In the extinction group (extinction;
group 3), no verbal suggestion was provided. In accordance with the electrical itch stimuli, the
histamine itch stimulus was preceded by a flashing colored cue of one second on the computer
screen. Even though participants were told that a purple or yellow light could be displayed, the
color that was previously used for the conditioned trials (purple or yellow, depending on the
randomization) was displayed. Moreover, the intensity of the histamine itch stimulus was,
alike the testing phases in part 1 and 2 of the electrical stimulation equal for all groups.
Throughout the experiment participants were also videotaped in order to record scratching
behavior and saliva was collected for DNA analyses (results will be reported elsewhere). The
session was concluded with some questions regarding the perceived intensity of the itch sti-
muli and an open question to check whether participants were aware of the goal of the study.
During the test session, there were several standardized breaks. During the breaks, partici-
pants were provided a selected number of magazines to read, with neutral content (about
nature and home decoration), and they were offered small snacks, Rooibos tea and water.
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Since participants sat down during the whole experiment, in the break after testing phase 1
participants took a short 2-minute walk within the research area of the university to stretch
their legs, and used a home trainer in the lab at a slow pace for 5 minutes. There were no
breaks between the learning and testing phases; the testing phases occurred immediately, with-
out any signal.
Statistical analyses
All analyses were determined a priori in consultation with a statistician. The required sample
size for the primary analysis was calculated with help from a statistician based on our previous
study [15]. The analysis was approached in Gpower 3.1 [46] as two two-tailed independent
samples t-tests with Bonferroni correction. With an effect size d = 0.78, alpha α = 0.025 and a
desired power of 0.80, this resulted in the largest required total sample size of 99 participants.
In total 30 participants were excluded from data analysis on the basis of criteria determined in
advance: for 1 participant, the experimenter provided a wrong combination of the conditioned
cue with the verbal suggestion; 3 participants dropped out due to equipment failure; and 25
participants were excluded because they experienced little to no itch after repeated electrical
itch induction (see also Fig 2. for more details on the number of participants at the different
stages of the study). With the permission of the local ethical committee, it was decided to
exclude all participants who rated the mean level of itch they experienced as< 1 itch on an
NRS with regard to the itch stimuli associated with the neutral stimuli in the testing phase of
part 2. These participants were replaced by randomly selected new participants. The statistical
analyses were conducted over the participants who experienced 1 itch on an NRS (n = 99).
However, sensitivity analyses were also carried out for all 124 participants who completed the
study, of whom 25 had experienced < 1 itch on an NRS. All analyses were performed using
SPSS 23.0 for Windows (IBM SPSS Statistics, Chicago, Illinois, USA). The nocebo effect was
defined as the difference between the mean itch NRS scores associated with the four trials with
the supposed activation of the third electrode (conditioned trials) and the four trials without
the supposed activation of the third electrode (neutral trials) in the testing phase. A positive
score indicated a nocebo effect.
Where the assumptions of the statistical tests (e.g., of normality) were violated, the data was
transformed or non-parametric tests were used (if feasible). With regard to the nocebo effect
in part 1 there was a problem with regard to normality of the data in the learning and testing
phase. Although transformation did not result in normal distribution, parametric tests were
reported, as non-parametric analyses obtained similar results.
Before conducting the main analysis, a paired samples t-test was performed to investigate
whether there was a nocebo effect in the first part of the experiment by comparing the mean
itch NRS score associated with the conditioned and neutral trials in the testing phase of part 1.
As a manipulation check, the effectiveness of the negative expectation induction procedure
during the learning phase was also assessed in an exploratory manner. To this end, a paired
samples t-test was again performed as described above, exploring the difference in itch NRS
scores between the conditioned and neutral trials in the learning phase of part 1.
Next, a univariate analysis of variance (ANOVA) was performed with group as between-
subject factor in the second part of the experiment, in order to test the main hypothesis, i.e.,
that the positive expectation induction group would display a significantly smaller nocebo effect
than the control groups (negative expectation induction group or extinction group). Post hoc
Dunnett tests were conducted to compare the positive expectation induction group with each of
the control groups. As a manipulation check, the effectiveness of the expectation induction pro-
cedures during the learning phase was also assessed in an exploratory manner. Again, an
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ANOVA with post hoc Dunnett tests was performed, exploring the difference in change in
itch NRS scores between the groups of part 2.
In order to exploratively assess generalization of reduced nocebo effects to histamine ionto-
phoresis, first the mean itch NRS score was calculated for each participant (assessed at 0:30,
1:00, 1:30, 2:00, and 2:30 min). Next, an ANOVA was performed with group as between-sub-
ject factor and the mean itch NRS score during histamine application as dependent variable.
Fig 2. CONSORT flowchart.
https://doi.org/10.1371/journal.pone.0182959.g002
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Post hoc Dunnett tests were conducted to compare the positive expectation induction group
with each of the control groups.
For exploratory purposes, Pearson correlation coefficients were calculated between the
nocebo effects in the first as well as the second part (for each group separately) and question-
naire scores for psychological characteristics. For all analyses, the level of significance was set
at p<0.05.
Results
In part 1, negative expectations were induced in all participants (induction nocebo effect). In
part 2 (reversing nocebo effect), randomization of the participants across the three groups
resulted in a total of 34 participants in the positive expectation induction group, 34 participants
in the negative expectation induction group, and 31 participants in the extinction group. The
characteristics of age, gender, use of hormonal contraceptives, baseline levels of itch, pain and
fatigue on the test day, and baseline levels of itch, pain and fatigue before histamine iontopho-
resis for the randomized participants were similar in the groups (see Table 1).
Induction of negative expectations (part 1)
Learning phase. As a manipulation check, the itch NRS scores evoked during the learning
phase of part 1 were assessed. This involved the induction of negative expectations for all partic-
ipants; both verbal suggestion and conditioning were applied. Table 2 displays the means (±SD)
of the stimuli associated with the conditioned and neutral trials. A paired samples t-test revealed
a significantly higher mean itch NRS score for the conditioned trials (M = 5.2, SD = 1.7) than
for the neutral trials (M = 4.0, SD = 1.7) (t(98) = 12.55, p<0.001, d = 1.26). This result shows
that the conditioning with verbal suggestion procedure was effective in inducing increased itch
in the conditioned trials relative to the neutral trials.
Table 1. Participant characteristics.
1. Positive expectation induction 2. Negative expectation induction 3. Extinction
Age 20.4 ± 2.7 20.3 ± 2.7 19.9 ± 1.9
Male/female ratio % 26.5/73.5% 23.5/76.5% 19.4/80.6%
Hormonal contraceptives % 50.0% 50.0% 54.8%
Itch baseline test day NRS 0.6 ± 0.7 0.6 ± 0.7 0.6 ± 0.7
Pain baseline test day NRS 0.4 ± 0.9 0.4 ± 0.5 0.5 ± 0.7
Fatigue baseline test day NRS 2.4 ± 1.5 2.1 ± 1.5 2.1 ± 1.3
Itch baseline histamine NRS 1.0± 1.1 0.9 ± 1.1 0.6 ± 0.7
Pain baseline histamine NRS 0.7 ± 1.0 0.6 ± 0.6 0.6 ± 0.8
Fatigue baseline histamine NRS 3.6 ± 1.7 3.6 ± 1.3 3.8 ± 1.5
Characteristics of the participants in the positive expectation induction group (group 1; n = 34), the negative expectation induction group (group 2; n = 34),
and the extinction group (group 3; n = 31).
https://doi.org/10.1371/journal.pone.0182959.t001
Table 2. Means (±SD) for itch NRS scores in the learning and testing phase in part 1 (induction of negative expectations).
Itch NRS scores (M ± SD)
Conditioned trials Neutral trials Change in itch score
Learning phase 5.2 ± 1.7 4.0 ± 1.7 1.2 ± 0.9
Testing phase 3.6 ± 1.9 3.2 ± 1.9 0.4 ± 0.8
Means (M) and standard deviations (SD) of the numerical rating scale (NRS) scores for itch and change itch NRS score (itch NRS score in conditioned trials
minus neutral trials) in the learning phase and testing phase for the induction of negative expectations in part 1 (n = 99).
https://doi.org/10.1371/journal.pone.0182959.t002
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Testing phase. In the testing phase of part 1, all participants received the same stimuli,
which were applied at medium intensity. Table 2 displays the means (±SD) of the itch NRS
scores evoked by the stimuli associated with the conditioned and neutral trials. A paired sam-
ples t-test revealed a significantly higher mean itch NRS score for the conditioned trials
(M = 3.6, SD = 1.9) than for the neutral trials (M = 3.2, SD = 1.8) (t(98) = 4.85, p< .001,
d = 0.49), indicating a significant nocebo effect in part 1.
Reversing nocebo effect (part 2)
Learning phase. As a manipulation check, the itch NRS scores evoked during the
learning phase of part 2 were assessed. Depending on the group, positive or negative
expectations were induced by conditioning with verbal suggestion or an extinction proce-
dure was applied. Table 3 displays the mean (±SD) itch NRS scores evoked by the stimuli
associated with the conditioned and neutral trials during the learning phases for each
group. When we tested whether the mean change itch NRS score (conditioned trials minus
neutral trials) would be smaller in the positive expectation induction group in than in the
control groups, univariate analysis of variance (ANOVA) revealed a significant group effect
(F(2,96) = 75.39, p<0.001, ηp2 = 0.61). Post hoc Dunnett tests indicated a significantly
larger itch NRS change score between the conditioned and neutral trials, for the positive
expectation induction group (M = -1.5, SD = 1.0) as compared to the negative expectation
induction group (M = 1.2, SD = 0.8) (p = < 0.001) as well as the extinction group (M = 0.7,
SD = 1.0)(p<0.001). This result reveals that the positive conditioning procedure was effec-
tive in inducing decreased itch in the conditioned trials relative to the neutral trials, in
comparison with the control groups.
Testing phase. In the testing phase of part 2, all participants received the same stimuli,
which were applied at medium intensity. Table 4 displays the mean (±SD) itch NRS scores
evoked by the stimuli associated with the conditioned and neutral trials during the testing
Table 3. Means (±SD) for itch NRS scores in the learning phase for the different groups in part 2.
Itch NRS scores (M ± SD)
Conditioned trials Neutral trials Change in itch score
Group 1—Positive expectation induction 1.9 ± 1.5 3.3 ± 1.0 -1.5 ± 1.0
Group 2 –Negative expectation induction 4.2 ± 1.5 3.0 ± 1.5 1.2 ± 0.8
Group 3 –Extinction 3.8 ± 1.6 3.1 ± 1.6 0.7 ± 1.0
Means (M) and standard deviations (SD) of the numerical rating scale (NRS) scores for itch and for the change itch score (itch NRS score conditioned trials
minus neutral trials) in the positive expectation induction group (group 1; n = 34), the negative expectation induction group (group 2; n = 34) and the
extinction group (group 3; n = 31) in the learning phase of part 2.
https://doi.org/10.1371/journal.pone.0182959.t003
Table 4. Means (±SD) for itch NRS scores in the testing phase for the different groups in part 2.
Itch NRS scores (M ± SD)
Conditioned trials Neutral trials Change in itch score
Group 1—Positive expectation induction 2.4 ± 1.5 2.9 ± 1.5 -0.4 ± 1.0
Group 2 –negative expectation induction 3.4 ± 1.7 2.9 ± 1.9 0.5 ± 0.8
Group 3 –Extinction 2.9 ± 1.9 2.6 ± 1.9 0.3 ± 0.9
Means (M) and standard deviations (SD) of the numerical rating scale (NRS) scores for itch and for the change in itch score (itch NRS score conditioned
trials minus neutral trials) in the positive expectation induction group (group 1; n = 34), the negative expectation induction group (group 2; n = 34) and the
extinction group (group 3; n = 31) in the testing phase of part 2.
https://doi.org/10.1371/journal.pone.0182959.t004
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phase for each group. The mean nocebo effect for each group is shown in Fig 3. When we
tested the main hypothesis that the nocebo effect would be smaller in the positive expectation
induction group than in the control groups, univariate ANOVA showed a significant difference
in the magnitude of the nocebo effect in the various groups (F(2,96) = 9.93, p<0.001, ηp2 =
0.17). Post hoc Dunnett tests comparing the experimental group with the control groups indi-
cated a significantly smaller nocebo effect in the positive expectation induction group (M = -0.4,
SD = 1.0) than in the negative expectation induction group (M = 0.5, SD = 0.8) (p<0.001) and
the extinction group (M = 0.3, SD = 0.9) (p = 0.003) (See Fig 3.).
Generalization of nocebo effects to histamine iontophoresis
When we explored whether the reduced nocebo effect generalized to the histamine stimulus,
an ANOVA showed a significant main effect for the groups with regard to the mean itch NRS
score during histamine application (F(2,96) = 5.293, p<0.01, ηp2 = 0.10). Post hoc Dunnett
tests comparing the experimental group with the control groups indicated significantly lower
itch NRS scores in the positive expectation induction group (M = 5.7, SD = 0.3) than in the nega-
tive expectation induction group (M = 6.8, SD = 0.3) (p<0.01) and marginally significant itch
NRS scores in the positive expectation induction group than in the extinction group (M = 6.5,
SD = 0.3) (p = 0.058).
Psychological characteristics
When we calculated correlation coefficients between the nocebo effect in part 1 (induction
negative expectations) and psychological characteristics, no significant correlations were
found. Similarly, when we calculated correlations coefficients between the psychological char-
acteristics and the nocebo effect in part 2 for each group separately (reversing nocebo effect),
no significant correlations were found.
Sensitivity analyses
Sensitivity analyses were conducted regarding the main analysis to assess the influence of
excluding the data of 25 participants who experienced little to no itch after repeated electrical
Fig 3. Nocebo effect. Means and standard error of the mean (error bars) of the numerical rating scale (NRS)
itch scores for the nocebo effect (change in itch NRS score between the four conditioned and four neutral
trials) of the different groups in the testing phase of part 2 (higher value indicates higher nocebo effect). The
asterisks show the level of significance related to the post hoc Dunnett comparison (***p<0.001; **p<0.01).
https://doi.org/10.1371/journal.pone.0182959.g003
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itch induction (< 1 itch on an NRS, see methods, statistical analyses). When all 124 participants
who completed the study were included, similar effects were found. More specifically, when
we investigated whether there was a significant nocebo effect in the testing phase of part 1, a
paired samples t-test revealed a significantly higher mean itch NRS score for the conditioned
trials (M = 3.2, SD = 2.0) than for the neutral trials (M = 2.8, SD = 1.9) (t(123) = 5.45, p< .001,
d = 0.96). This indicates that the nocebo effect in part 1 was significant. When we tested the
main hypothesis that, if all 124 participants were included, the nocebo effect in part 2 would be
smaller in the positive expectation induction group than in the control groups, univariate
ANOVA showed a significant difference in the magnitude of the nocebo effect in the various
groups (F(2, 121) = 12.23, p< 0.001, ηp2 = 0.17). Post hoc Dunnett tests comparing the experi-
mental group with the control groups indicated a significantly smaller nocebo effect in the pos-
itive expectation induction group (n = 43) (M = -0.4, SD = 0.9) than the negative expectation
induction group (n = 42) (M = 0.5, SD = 0.8) (p< 0.001) and in the extinction group (n = 39)
(M = 0.3, SD = 0.9) (p< 0.01).
Discussion
The present study demonstrates, for the first time, that nocebo effects induced by conditioning
with verbal suggestion can be minimized and even reversed by positive expectation induction
by means of counterconditioning with verbal suggestion. Participants who received the posi-
tive expectation induction experienced significantly less itch than participants in the control
groups, who received either continued negative expectation induction or an extinction proce-
dure. Moreover, these results generalized to a second itch stimulus. These results demonstrate
that a single session of counterconditioning with verbal suggestion is sufficient to reverse pre-
viously induced nocebo effects and elicit placebo effects.
In line with our previous studies on nocebo effects on itch [14, 15], exposing the partici-
pants to negative expectations (i.e., expectations for high levels of itch) regarding the condi-
tioned trials, resulted in significantly higher levels of itch in response to the conditioned trials
than to the neutral trials; this indicates that the nocebo induction was successful. This finding
replicates results from a previous study [15], in which we demonstrated that nocebo effects on
itch can be induced by the combination of conditioning and verbal suggestion. This is in
accordance with studies on other physical symptoms like pain [19–21]. Furthermore, the result
is consistent with previous studies that demonstrate that verbal suggestion alone can induce
nocebo effects, or nocebo-like effects, on itch [14, 16, 47, 48]. The current study not only repli-
cates the finding that nocebo effects on itch can be induced by conditioning and verbal sugges-
tion [15], but also extends this by demonstrating that nocebo effects can be reversed. To the
best of our knowledge, this is the first time that this has been investigated.
Positive expectation induction in the conditioned trials resulted in a significantly smaller
nocebo effect than in the control groups, in which negative expectations were induced or an
extinction procedure was applied. Moreover, the nocebo effect after positive expectation
induction even demonstrated a significant placebo effect. Additional support for these findings
was found in the learning phase, in which there was a similar pattern of changes in itch scores
in response to conditioned and neutral trials. This finding extends results of a recent study on
nocebo-like effects induced by verbal suggestions, which provided some initial indications that
positively framed information regarding the health effects of wind turbine sound can dilute or
even reverse the effects of negative expectations [22]. The successful reversal of the nocebo
effect on itch by means of a counterconditioning procedure is consistent with a large body of
research that shows that counterconditioning is an effective way of changing learned behavior
in, for example, fear and evaluative conditioning paradigms [23–25, 32]. Furthermore, the
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finding that counterconditioning by inducing positive expectations was more effective than an
extinction procedure in reversing the nocebo effect is also in accordance with conditioning
studies that indicate that counterconditioning might be more effective than extinction in
changing conditioned effects [23–25, 32].
In the current study, the extinction procedure did not significantly reduce nocebo effects.
This is in line with previous studies on pain showing that nocebo effects eventually decrease
but often do not fully eliminate the learned behavior, especially when a high number of condi-
tioning trials is used [19, 45, 49]. Since in these studies and the current one the number of
extinction trials was limited to a maximum of 10, it is currently unknown whether nocebo
effects might be extinguished after more extinction trials or after several days. Similarly, evalu-
ative conditioned effects seem less sensitive to extinction than conditioned fear responses,
which often do become extinct after extinction trials [19, 45, 49]. In evaluative conditioning
this is explained by the fact that the nonoccurrence of the US disconfirms the predictive value
of the CS, but still evokes the representation of the US with the accompanying evaluation [31,
32]. More research is needed to establish whether similar processes could play a role in nocebo
effects.
We found indications that the reduced nocebo effect generalized to a second, different itch
stimulus i.e., histamine iontophoresis. The demonstration of possible generalization to other
stimuli lends weight to the effectiveness of the counterconditioning with verbal suggestion
procedure for the reduction of nocebo effects. However, future research should investigate
whether this generalization is still effective without repeating verbal suggestions, as it was
applied in our study before the histamine application. Moreover, this finding supports the
external validity of the counterconditioning with verbal suggestion paradigm employed in this
experiment. Therefore, also for other physical sensations like pain, it would be highly relevant
to investigate the reversibility of nocebo effects, to get insight into expectancy learning in
reversing nocebo effects across different sensations.
In the present study we did not find any significant correlations with the psychological
characteristics examined. Previous studies regarding nocebo effects on itch have found indica-
tions for a role of psychological characteristics in relation to negative outcome expectancies,
like worrying or negative affect, however research is extremely scarce [50]. Moreover, in a
recent study by our research group, indications were found that one’s cognitive schemas
regarding specificity and valence of memories and expectations regarding itch are related to
placebo responding on itch, i.e., participants who were more specific in their memories regard-
ing itch and who had less negative itch-related expectations for the future were more likely to
be placebo itch responders [33]. Future research should further investigate the determinants of
(reversing) nocebo responses, like individual differences in psychological characteristics in
relation to negative outcome expectancies and cognitive schemas regarding memories and
expectations.
Several implications for future research and clinical practice should be considered. First,
the counterconditioning with verbal suggestion paradigm could possibly be applied to other
experimental models of itch, like mechanical itch stimuli, to study different itch pathways that
are relevant for different types of pruritus that can be seen in clinical practice [51, 52]. Second,
it remains to be established whether these findings in healthy participants can be generalized
to patients in a clinical setting. Two studies regarding contagious itch suggest that patients
with chronic itch complaints might respond more strongly to visual or audiovisual itch cues
than healthy controls [13, 53]. Additionally, several neuroimaging studies demonstrate differ-
ences in brain activation when itch is experimentally induced in patients versus in healthy
controls [54, 55], emphasizing the need to study the placebo and nocebo effects on itch sepa-
rately for healthy controls and patients. Furthermore, future research should investigate how
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experimental conditioning paradigms can be used in clinical practice. For example pharma-
cotherapeutic conditioning designs regarding itch medication, aimed at reducing the dose of
medication could be examined. For example, a related format has been used in a study in
patients with allergic rhinitis, in which an H1 receptor antagonist was conditioned with a
novel-tasting drink, and in the testing phase replaced by a placebo with the drink. Patients
reported less subjective symptoms and showed a reduced skin response to the skin prick test
when administering the drink along with a placebo pill [6]. Future research could set up a sim-
ilar design with reducing the dosage of itch medication to diminish possible side effects while
the therapeutic benefits of the medication are preserved [56]. Minimizing possible nocebo
effects could be an important ingredient of individually tailored care interventions for chronic
somatic conditions [11, 57, 58]. This may be particularly important for patients with negative
expectations regarding the given treatment, for example for patients with negative treatment
experiences or certain personality characteristics related to negative treatment outcomes (e.g.,
worrying), or for patients who are excessively afraid of side effects [1, 50, 59, 60].
A possible limitation of this study is that reversal of the nocebo effect was tested in a single
session. It would be highly relevant to test whether the reversed nocebo effect, i.e., placebo
effect, remains on subsequent days, whether it extinguishes, or whether the nocebo effect
recurs. Furthermore, we did not investigate the influence of the filler tasks provided between
the electrical itch stimuli. Although we selected different tasks that were in general not too
challenging and as neutral as possible, we cannot exclude a possible influence on for example
mood, which can vary between individual participants. In addition, we did not assess partici-
pants’ expectations over the course of the study, so we cannot exclude the possibility that fac-
tors other than expectancy learning might be responsible for the effects found in this study.
Moreover, assessing participants’ expectations in future studies would provide valuable data
on how the induction of negative and subsequently of positive expectations affects patients’
expectations overall, and on the extent to which these expectations mediate nocebo effects.
In conclusion, this study demonstrates that nocebo effects can be effectively minimized by
positive expectation induction and can even turn into placebo effects. Moreover, countercon-
ditioning of nocebo effects regarding one stimulus can possibly generalize to another similar
stimulus. Whereas more research is needed, the results of the current study show first indica-
tions that learning via counterconditioning and verbal suggestion may represent a promising
strategy for diminishing nocebo responses.
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